Sylvain Martel

Professor, Tier 1 Canada Research Chair in Medical Nanorobotics
Director, NanoRobotics Laboratory
Polytechnique Montréal
Adjunct Professor, Bioengineering Dept., McGill University

Transpotherapy: Therapy based on nanorobotic transporters

In cancer therapy for instance, when surgical resection is no longer a viable option, chemotherapy, radiotherapy, and immunotherapy are presently the main therapeutic modalities used to treat cancers. Although the large majority including many metastatic cancers are localized, the ability to transport non-systematically therapeutic agents to spatially-located cancerous sites would maximize the treatment efficacy for all these treatment modalities while minimizing systemic toxicity or side effects for the patients. This new paradigm dubbed transpotherapy could be the next game-changer in the fight against most cancers. An introductory review of the main existing approaches that could potentially help transpotherapy to become the next cancer treatment modality will be presented.